Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Organ Site Research

Abstract C40: A biopsy-focused approach to molecular studies of prostate cancer in African Americans: the Birmingham Alabama Prostate Cancer Consortium (BAPrCa)

Sandra M. Gaston, Dennis Otali, James Kearns, Kerry Dehimer, George W. Adams, Soroush Rais-Bahrami, Jeffrey Nix, James E. Bryant, Peter Kolettis and William E. Grizzle
Sandra M. Gaston
1Tufts Medical Center, 02111, Massachusetts,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis Otali
2University of Alabama at Birmingham, Birmingham, Alabama,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Kearns
1Tufts Medical Center, 02111, Massachusetts,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerry Dehimer
1Tufts Medical Center, 02111, Massachusetts,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George W. Adams
3Urology Centers of Alabama, Birmingham, AL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soroush Rais-Bahrami
2University of Alabama at Birmingham, Birmingham, Alabama,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Nix
2University of Alabama at Birmingham, Birmingham, Alabama,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James E. Bryant
2University of Alabama at Birmingham, Birmingham, Alabama,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Kolettis
2University of Alabama at Birmingham, Birmingham, Alabama,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William E. Grizzle
2University of Alabama at Birmingham, Birmingham, Alabama,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7755.DISP16-C40 Published February 2017
  • Article
  • Info & Metrics
Loading
Abstracts: Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 25-28, 2016; Fort Lauderdale, FL

Abstract

Cancer health disparities can arise from research studies in which the study subjects are not representative of the populations affected by the disease. In prostate cancer (PrCa) biorepositories, most of the frozen samples collected for molecular analyses are obtained from radical prostatectomy (RP) specimens. However, tissue collections based on RP specimens do not include patients who are diagnosed with relatively advanced disease and treated with first-line hormonal and/or radiation therapy rather than surgery; African Americans (AA) are more likely than European Americans (EA) to be diagnosed with this type of advanced prostate cancer. With support from the DOD Prostate Cancer Research Program, our research team has established the Birmingham Alabama Prostate Cancer Consortium (BAPrCa) with a major focus on studies that use prostate biopsies for the molecular analysis of PrCa in AAs. To ensure that there is no compromise of biopsy diagnosis, we use innovative tissue print technologies to obtain snap frozen nitrocellulose blots from each of the prostate biopsy cores. These biopsy tissue prints provide high quality RNA and DNA for molecular and genetic studies. Our biopsy-based analysis of high risk cancers has revealed PrCa subtypes that were either unrecognized or significantly underestimated in previous prostatectomy-based studies.

As of June 2016 more than 250 prostate biopsy patients have been prospectively enrolled in the BAPrCa prostate biopsy tissue print study; just under half (48%) of these study subjects self-identify as AA. Each biopsy from each study subject was tissue printed to generate more than 3000 unique pairs of high quality RNA and DNA samples. AA men were enrolled from two study sites in Birmingham Alabama, an academic medical center (University of Alabama at Birmingham, UAB) and a large urology private practice (Urology Centers of Alabama, UCA). The prevalence of prostate cancer diagnosed in our AA study subjects undergoing standard biopsies was 51%, with 30% showing cancer of Gleason 7 or more. A higher proportion of AA subjects were diagnosed with PrCa at UAB (61% cancer positive; 45% with Gleason 7 or more) compared to UCA (44% cancer positive; 20% with Gleason 7 or more). The difference between AA cancer diagnoses observed between our two study sites may in part result from differences in the criteria for biopsy; pre-biopsy PSA was less than 4 ng/ml for 25% of UCA subjects but for only 2% of UAB subjects.

PSA criteria for prostate biopsy may have a significant and unrecognized impact on the detection of prostate cancer in contemporary AA populations. The BAPrCa study cohort provides a unique opportunity to evaluate the PrCa subtypes diagnosed in AAs using different PSA criteria for biopsy, especially in a deep south AA population.

Citation Format: Sandra M. Gaston, Dennis Otali, James Kearns, Kerry Dehimer, George W. Adams, Soroush Rais-Bahrami, Jeffrey Nix, James E. Bryant, Peter Kolettis, William E. Grizzle. A biopsy-focused approach to molecular studies of prostate cancer in African Americans: the Birmingham Alabama Prostate Cancer Consortium (BAPrCa). [abstract]. In: Proceedings of the Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2016 Sep 25-28; Fort Lauderdale, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2017;26(2 Suppl):Abstract nr C40.

  • ©2017 American Association for Cancer Research.
Previous
Back to top
Cancer Epidemiology Biomarkers & Prevention: 26 (2 Supplement)
February 2017
Volume 26, Issue 2 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract C40: A biopsy-focused approach to molecular studies of prostate cancer in African Americans: the Birmingham Alabama Prostate Cancer Consortium (BAPrCa)
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract C40: A biopsy-focused approach to molecular studies of prostate cancer in African Americans: the Birmingham Alabama Prostate Cancer Consortium (BAPrCa)
Sandra M. Gaston, Dennis Otali, James Kearns, Kerry Dehimer, George W. Adams, Soroush Rais-Bahrami, Jeffrey Nix, James E. Bryant, Peter Kolettis and William E. Grizzle
Cancer Epidemiol Biomarkers Prev February 1 2017 (26) (2 Supplement) C40; DOI: 10.1158/1538-7755.DISP16-C40

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract C40: A biopsy-focused approach to molecular studies of prostate cancer in African Americans: the Birmingham Alabama Prostate Cancer Consortium (BAPrCa)
Sandra M. Gaston, Dennis Otali, James Kearns, Kerry Dehimer, George W. Adams, Soroush Rais-Bahrami, Jeffrey Nix, James E. Bryant, Peter Kolettis and William E. Grizzle
Cancer Epidemiol Biomarkers Prev February 1 2017 (26) (2 Supplement) C40; DOI: 10.1158/1538-7755.DISP16-C40
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Organ Site Research

  • Abstract A74: [Advocate Abstract:] The brown faces of colorectal cancer
  • Abstract A82: Disparities in prostate cancer incidence, patient and clinical characteristics among Latino subpopulations defined by country of origin in California: Findings from the California Cancer Registry
  • Abstract A69: Racial disparity in breast cancer hospital treatment costs: Examining the effect of depression
Show more Organ Site Research

Genitourinary Cancers

  • Abstract A82: Disparities in prostate cancer incidence, patient and clinical characteristics among Latino subpopulations defined by country of origin in California: Findings from the California Cancer Registry
  • Abstract A79: Establishment of African American prostate cancer patient-derived primary cell lines and xenografts
  • Abstract A83: Decreased nuclear expression of the E3 ubiquitin ligase Nrdp1 in African American men compared to Caucasian men with localized prostate cancer
Show more Genitourinary Cancers

Genitourinary Cancers: Poster Presentations - Proffered Abstracts

  • Abstract A82: Disparities in prostate cancer incidence, patient and clinical characteristics among Latino subpopulations defined by country of origin in California: Findings from the California Cancer Registry
  • Abstract A79: Establishment of African American prostate cancer patient-derived primary cell lines and xenografts
  • Abstract A83: Decreased nuclear expression of the E3 ubiquitin ligase Nrdp1 in African American men compared to Caucasian men with localized prostate cancer
Show more Genitourinary Cancers: Poster Presentations - Proffered Abstracts
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement